French To Speed Up Early Access Procedure
Drug Price Cuts Also In The Offing, But Less Than Expected
Executive Summary
The French government is to implement a simplified mechanism for making new, innovative medicines available to patients more quickly before they are formally approved for marketing. The target for reimbursement spending on health care in general has been increased for 2021 and includes a special provision for coronavirus-related expenditure.